查詢結果分析
相關文獻
- 術後隅角狹窄程度與雅鉻雷射虹膜穿孔術療效之關係
- Corneal Opacity and Congenital Glaucoma Associated with Massive Heparan Sulfaturia: Report of One Case
- 碳酸酐酶抑制劑6-Hydroxyethoxy-2-benzothiazole Sulfonamide靜脈注射後之兔眼藥物動力學
- 碳酸酐酶抑制劑6-Hydroxyethoxyzolamide局部點眼後之兔眼藥物動力學
- Carteolol (Arteoptic[feb9])之臨床評估及心血管作用--內因性擬交感神經作用之探討
- Timoptol-XE[feb9] 及Timoptol[feb9] 用於青光眼或高眼壓症病人之比較性研究
- 抑制細胞增生藥物在青光眼濾過造口術的應用
- 雅鉻雷射虹膜穿孔術於急性隅角閉鎖性青光眼的臨床結果
- 藥物導致的青光眼
- Dorzolamide(Trusopt[feb9])--第一個Carbonic Anhydrase Inhibitor眼滴劑
頁籤選單縮合
題 名 | 術後隅角狹窄程度與雅鉻雷射虹膜穿孔術療效之關係=Gonioscopy and Efficacy of Neodymium: YAG Laser Iridotomy in Angle Closure Glaucoma |
---|---|
作 者 | 沈素琴; 許慶堂; 蕭靜熹; 陳賢立; | 書刊名 | 中華民國眼科醫學會雜誌 |
卷 期 | 38:4 1999.12[民88.12] |
頁 次 | 頁627-634 |
分類號 | 416.703 |
關鍵詞 | 隅角狹窄; 雅鉻雷射虹膜穿孔術; 青光眼; Nd: YAG laser iridotomy; Primary angle closure glaucoma; Gonioscopy; |
語 文 | 中文(Chinese) |
中文摘要 | 目的:長期追蹤雅鉻雷射虹膜穿孔術治療隅角閉鎖性青光眼的結果,並且評估術 後隅角狹窄程度對於預測雅鉻雷射虹膜穿孔術治療效果所扮演的角色。 方法:針對長庚醫院三年間患有急性或慢性隅角閉鎖性青光眼之83隻患眼,施行雅鉻雷 射虹膜穿孔術治療,平均追蹤51個月(從12.5個月到102個月)比較急性和慢性隅角閉鎖性 青光眼的下列臨床資料,包括:年齡,性別,視力,眼壓,隅角情形等。 結果:大多數患眼(76.8%)經由雅鉻雷射虹膜穿孔術治療都能降低眼壓,只有10眼仍須 要濾過手術來控制眼壓。在術後六個月的追蹤治療中,大部分的患眼(84.6%)視力維持不變 或獲得改善。白內障惡化是其他患眼視力減退的主因。在大多數的患眼(87.9%)中,雅鉻雷 射虹膜穿孔術治療排除了進一步手術治療的必要;但在12隻隅角黏合閉鎖大於270度的患眼 中,仍有8眼須要進一步的手術來控制眼壓。54.1%的患眼有暫時性的眼壓升高,22.9%的患 眼有虹彩出血,其他的合併症很少發生。 結論:用雅鉻雷射虹膜穿孔術治療隅角狹窄性青光眼是一個安全有效的治療方式,而術 後隅角狹窄程度對於預測雅鉻雷射虹膜穿孔術治療的效果更扮演了一個重要的角色。 |
英文摘要 | Purpose: To assess the long-term results of Neodymium: YAG (Nd:YAG) laser iridotomy for the management of patients with primary angle closure glaucoma and the role of gonioscopy in predicting the outcome after Nd:YAG laser iridotomy. Methods: Laser peripheral iridotomies were performed on 83 eyes with acute or chronic primary angle closure glaucoma in Chang Gung Memorial Hospital. The mean follow-up period was 51 months, ranged from 12.5 to 102 months. The clinical data, including age, gender, Snellen visual acuity, intraocular pressure, and gonioscopic findings, were compared between acute and chronic primary angle closure glaucoma. Results: Decreased intraocular pressure (IOP) was noted in most eyes after Nd:YAG laser iridotomy (76.8%); only 10 eyes required further filtrating surgery to control intraocular pressure. Visual acuity remained unchanged or improved in the great majority (84.6%) of cases after 6-months follow up. Cataract progression was primarily responsible for those eyes with decreased acuity. Laser iridotomy, with or without medical treatment, obviated further surgical treatment in most categories; but eight of 12 eyes with severe peripheral anterior synechiae (PAS>270°) underwent further surgery to control IOP. Transient elevated IOP and iris bleeding occurred in 54.1 % and 22.9% of eyes, respectively; other complications were rare. Conclusions: Nd:YAG laser iridotomy is a safe and effective procedure in the treatment of angle closure glaucoma. The gonioscopy plays an important role in predicting the outcome after Nd:YAG laser iridotomy. |
本系統中英文摘要資訊取自各篇刊載內容。